Mirikizumab is a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis. Pharmaceutical company Eli Lilly recently released findings of two studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback